Le Lézard
Classified in: Health
Subjects: PER, MAT

Shiny Health & Wellness Appoints Meris Kott as CEO


Progress Towards Building A Strong Canadian Brand

TORONTO, Nov. 20, 2023 /CNW/ - Shiny Health & Wellness Corp. ("Shiny Health" or the "Company") (TSXV: SNYB) today announces that Ms. Meris Kott, a current Director has been appointed to the role of interim Chief Executive Officer ("CEO").

The Company further announces the resignation of Mr. Michael Nadeau as the Company's CEO and as a member of the Board of Directors effective November 18, 2023. The Board wishes Mike all the best in his future endeavors.

The Board of Directors feels Meris is the right person to step into the role as interim CEO and is well-positioned to continue advancing our strategy with the Board's ongoing support and oversight. Together with the deep bench of talent across the entire organization, she will ensure SNYB does not miss a beat.

Meris began her journey in cannabis in 2012 developing the first seed to sale dispensing terminal when Colorado was just the first state to approve recreational cannabis sales. She began helping to shape Canada's cannabis industry in 2018, launching a merchant bank to fund newly approved cannabis products and companies entering the new Canadian cannabis sector. She has keynoted at many cannabis conferences and spoken of her belief that the plant has many health and wellness benefits yet to be discovered. 

Meris' background is in the global public markets and investment banking, and she started her European experience in The Netherlands in 1983 working for an International Venture Group. In 1985, she moved to the United States where she worked for an American Investment Bank that specialized in funding emerging growth companies. Today, she is CEO of a disruptive psychedelic incubator Xtacy Therapeutics Corp. (a CSE listed corporation) that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The focus of Xtacy is on global wellness, psychedelics, mycology, hemp and CBD, healthcare-related target companies and their clinical studies and trials.

"I am extremely honored and excited to help Shiny Health & Wellness Corp close off Q4 with our new acquisition of Stash & Co., and look for further footholds throughout Canada, the USA and Europe. As someone who has ushered many companies to the next level in the sector, this Company is by far one my favorites, because of the unlimited potential I see ahead for all of us. In this nascent cannabis sector, there is so much more to discover from this plant and also accomplish for the Company and our supportive stakeholders." Said Meris Kott, Interim CEO and Director Shiny Health & Wellness Corp. 

About Shiny Health & Wellness
Shiny Health & Wellness Corp. is on a mission to help people never settle, live fully by being a trusted source for health and wellness solutions and services. The Company operates ShinyBud Cannabis Co., a well-established brand of adult-use dispensaries in Ontario strategically located in markets less saturated with cannabis retailers.

Shiny Health trades on the TSX Venture Exchange (TSXV) under the ticker symbol SNYB. For more information, please visit www.shinyhealthandwellness.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Shiny Health & Wellness Corp.


These press releases may also interest you

at 21:30
The "Hydroxypropyl Methylcellulose Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to  ResearchAndMarkets.com's offering. The latest industry analysis on the Hydroxypropyl Methylcellulose...

at 21:00
The "Asia-Pacific Contrast Media Agent and Injector System Market - Analysis and Forecast, 2022-2026" report has been added to  ResearchAndMarkets.com's offering. The Asia-Pacific contrast media agent and injector system market was valued at $1.98...

at 20:50
Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the pricing of its  underwritten public offering of 6,471,000...

at 20:34
The Honourable Mark Holland, Minister of Health, will make an announcement related to An Act Respecting Pharmacare. There will be a virtual media technical briefing with Government of Canada officials prior to the press conference. DateFebruary 29,...

at 19:30
The "Protein Expression Market - A Global and Regional Analysis: Focus on Application, End User, Product, Expression System, and Region - Analysis and Forecast, 2023-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 19:20
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced that MSCI, one of the...



News published on and distributed by: